The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world (RW) experience with atezolizumab + bevacizumab (A+B) for the treatment of unresectable HCC (uHCC): A multicenter study.
 
Maen Abdelrahim
Consulting or Advisory Role - AstraZeneca; Ipsen
 
Abdullah Esmail
No Relationships to Disclose
 
Richard Kim
Honoraria - Natera
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Eisai; Exelixis; Jazz Pharmaceuticals; Pfizer; Roche/Genentech; SERVIER; Taiho Oncology
Speakers' Bureau - AstraZeneca; Incyte
 
Sukeshi Arora
Honoraria - Targeted Oncology
Consulting or Advisory Role - Actuate Therapeutics; AstraZeneca; Exelixis; Seagen
Speakers' Bureau - AstraZeneca; Bristol-Meyers Squibb; Seagen
Travel, Accommodations, Expenses - DAVA Oncology
 
Junaid Arshad
Honoraria - Aptitude Health
Consulting or Advisory Role - Bristol-Myers Squibb/Roche; Deciphera; Elevar Therapeutics; Exelixis
 
Ioannis Kournoutas
No Relationships to Disclose
 
Conor O'Donnell
No Relationships to Disclose
 
Todor Totev
Research Funding - Arena Pharma (Inst); Astellas Pharma (Inst); BeiGene (Inst); bioMérieux, Inc. (Inst); Bristol-Myers Squibb (Inst); California Institute for Regenerative Medicine (CIRM) (Inst); Epizyme (Inst); Genentech/Roche (Inst); Janssen (Inst); Kiniksa (Inst); Lexicon (Inst); Merck (Inst); Moderna Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Regeneron (Inst); Takeda (Inst); Teva (Inst)
 
Amie Tan
Employment - Genentech
Stock and Other Ownership Interests - Genentech/Roche
Travel, Accommodations, Expenses - Roche/Genentech
 
Fan Mu
Employment - Analysis Group
 
Shravanthi Seshasayee
Employment - Analysis Group
 
Sairy Hernandez
Employment - Genentech
Stock and Other Ownership Interests - Genentech
Research Funding - Genentech
Patents, Royalties, Other Intellectual Property - HPK1 target as immunotherapy; HPK1 target as immunotherapy
Travel, Accommodations, Expenses - Genentech
 
Nguyen Tran
Honoraria - Helsinn Therapeutics (Inst); QED Therapeutics (Inst)
Consulting or Advisory Role - AstraZeneca (Inst); QED Therapeutics (Inst); TEMPUS (Inst)
Research Funding - Exact Sciences